Campbell Cut Its Dividend; Clorox Now Faces the Harder Test

Campbell's 36% dividend cut changed the comparison with Clorox. Campbell now pays $0.25 a quarter, or $1.00 annually, after management chose to redirect cash toward debt reduction. Clorox maintained its payout, but its latest cash flow leaves less protection than the unchanged dividend suggests.

Campbell's fiscal 2026 sales fell 5% to $9.7 billion, adjusted EBIT dropped 21%, and adjusted EPS declined 27% to $2.17. Cash from operations was $1.0 billion, while capital spending was $361 million. The company returned $496 million to shareholders, mostly through dividends, before resetting the payout for fiscal 2027. The cut was painful, but it brought the distribution closer to the earnings power of a weaker business.

Clorox paid $602 million of dividends against $405 million of fiscal 2026 free cash flow. Management expects organic sales to grow 3.5% to 4.5% in fiscal 2027 and adjusted EPS to reach $5.70 to $6.00. If those targets translate into cash, the current dividend can look more defensible. If freight, commodities or execution interfere, the gap remains.

Campbell has already absorbed the credibility cost of a cut; Clorox is asking investors to trust that its cash shortfall is temporary. That makes Campbell the lower-payout, deleveraging story and Clorox the higher-execution-risk recovery.

The better dividend choice depends on what an investor wants to underwrite. Campbell offers a reset base with weaker recent operations. Clorox offers continuity and a potentially stronger rebound, but the next year of free cash flow will decide whether continuity was prudence or delay.